Pancreatic ductal adenocarcinoma (PDAC) is a fatal disease with a very poor 5-year survival rate. a-Enolase is a glycolytic enzyme that also acts as a surface plasminogen receptor. We find that it is overexpressed in PDAC and present on the cell surface of PDAC cell lines. The clinical correlation of its expression with tumor status has been reported for lung and hepatocellular carcinoma. We have previously demonstrated that sera from PDAC patients contain IgG autoantibodies to a-enolase. The present work was intended to assess the ability of a-enolase to induce antigen-specific T cell responses. We show that a-enolase-pulsed dendritic cells (DC) specifically stimulate healthy autologous T cells to proliferate, secrete IFN-c and lyse PDAC cells but not normal cells. In vivo, a-enolase-specific T cells inhibited the growth of PDAC cells in immunodeficient mice. In 8 out of 12 PDAC patients with circulating IgG to a-enolase, the existence of a-enolase-specific T cells was also demonstrated. Taken as a whole, these results indicate that a-enolase elicits a PDAC-specific, integrated humoral and cellular response. It is thus a promising and clinically relevant molecular target candidate for immunotherapeutic approaches as new adjuvants to conventional treatments in pancreatic cancer.

An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma associated antigen

CAPPELLO, Paola;TOMAINO, BARBARA;CHIARLE, Roberto;CERUTI, PATRIZIA;GIOVARELLI, Mirella;NOVELLI, Francesco
2009-01-01

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a fatal disease with a very poor 5-year survival rate. a-Enolase is a glycolytic enzyme that also acts as a surface plasminogen receptor. We find that it is overexpressed in PDAC and present on the cell surface of PDAC cell lines. The clinical correlation of its expression with tumor status has been reported for lung and hepatocellular carcinoma. We have previously demonstrated that sera from PDAC patients contain IgG autoantibodies to a-enolase. The present work was intended to assess the ability of a-enolase to induce antigen-specific T cell responses. We show that a-enolase-pulsed dendritic cells (DC) specifically stimulate healthy autologous T cells to proliferate, secrete IFN-c and lyse PDAC cells but not normal cells. In vivo, a-enolase-specific T cells inhibited the growth of PDAC cells in immunodeficient mice. In 8 out of 12 PDAC patients with circulating IgG to a-enolase, the existence of a-enolase-specific T cells was also demonstrated. Taken as a whole, these results indicate that a-enolase elicits a PDAC-specific, integrated humoral and cellular response. It is thus a promising and clinically relevant molecular target candidate for immunotherapeutic approaches as new adjuvants to conventional treatments in pancreatic cancer.
25
639
648
http://www3.interscience.wiley.com/cgi-bin/fulltext/122207151/PDFSTART
human; pancreatic ductal adenocarcinoma; alpha enolase; tumor antigen; B cell response; T cell response
P. Cappello; B Tomaino; R. Chiarle; P. Ceruti; A. Novarino; C. Castagnoli; P. Migliorini; G. Perconti; A. Giallongo; M. Milella; V. Monsurrò; S. Barbi; A. Scarpa; P. Nisticò; M. Giovarelli; F. Novelli
File in questo prodotto:
File Dimensione Formato  
Cappello P.pdf

Open Access dal 31/08/2010

Descrizione: Versione post-print
Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 829.16 kB
Formato Adobe PDF
829.16 kB Adobe PDF Visualizza/Apri
Cappello P IntJCancer 2009.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 711.9 kB
Formato Adobe PDF
711.9 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/59126
Citazioni
  • ???jsp.display-item.citation.pmc??? 49
  • Scopus 89
  • ???jsp.display-item.citation.isi??? 89
social impact